-
Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial
D'Haens, G., Taxonera, C., Lopez-Sanroman, A., Nos, P., Danese, S., Armuzzi, A., Roblin, X., Peyrin-Biroulet, L., West, R., Mares, W. G. N., Duijvestein, M., Gecse, K. B., Feagan, B. G., Zou, G., Hulshoff, M. S., Mookhoek, A., Oldenburg, L., Clasquin, E., Bouhnik, Y. & Laharie, D., 1 Jan 2025, In: The Lancet Gastroenterology and Hepatology. 10, 1, p. 26-33 8 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Development and validation of peripheral blood DNA methylation signatures to predict response to biological therapy in adults with Crohn's disease (EPIC-CD): an epigenome-wide association study
Joustra, V. W., Li Yim, A. Y. F., Henneman, P., Hageman, I., de Waard, T., Levin, E., Noble, A. J., Chapman, T. P., Mol, F., van Zon, S., Lee, D., McGregor, C. G. C., Hulshoff, M. S., Satsangi, J. J., de Jonge, W. J., D'Haens, G. R. & EPIC-CD Consortium, 2025, (E-pub ahead of print) In: The Lancet Gastroenterology and Hepatology.Research output: Contribution to journal › Article* › Academic › peer-review
-
Cost-effectiveness and cost-utility of optimized mercaptopurine treatment versus placebo in ulcerative colitis patients: The randomized controlled OPTIC trial
Löwenberg, M., van Barreveld, M., Volkers, A., van Gennep, S., Duijvestein, M., van Bodegraven, A. A., Hulshoff, M. S., Jansen, J. M., van Asseldonk, D., West, R., D’Haens, G., de Boer, N. & Dijkgraaf, M. G. W., Nov 2024, In: United European gastroenterology journal. 12, 9, p. 1256-1265 10 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
